Issue 15, 2020

Hollow silicon microneedle fabrication using advanced plasma etch technologies for applications in transdermal drug delivery

Abstract

A novel production process flow is presented here for the manufacture of hollow silicon microneedles using deep reactive-ion etching (DRIE) technology. The patent-pending three-step process flow has been developed to produce multiple arrays of sharp-tipped, hollow microneedles, which facilitate easy insertion and controlled fluid injection into excised skin samples. A bevelled tip and vertical sidewalls for the microneedle have been achieved with good uniformity, despite >45% open etch area. Processing steps and etch challenges are discussed, and preliminary skin testing results are presented, showing effective needle insertion and delivery of fluorescent dye into ex vivo skin from human breast tissue.

Graphical abstract: Hollow silicon microneedle fabrication using advanced plasma etch technologies for applications in transdermal drug delivery

Article information

Article type
Paper
Submitted
01 Jun 2020
Accepted
20 Jun 2020
First published
07 Jul 2020
This article is Open Access
Creative Commons BY license

Lab Chip, 2020,20, 2788-2795

Hollow silicon microneedle fabrication using advanced plasma etch technologies for applications in transdermal drug delivery

C. J. W. Bolton, O. Howells, G. J. Blayney, P. F. Eng, J. C. Birchall, B. Gualeni, K. Roberts, H. Ashraf and O. J. Guy, Lab Chip, 2020, 20, 2788 DOI: 10.1039/D0LC00567C

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements